Search results
Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.
The Wall Street Journal· 6 days agoYou don’t need a home run to get Wall Street excited about a pill for obesity. When the market...
Structure Therapeutics Stock Soars on Obesity Pill Data
The Wall Street Journal· 6 days agoShares of Structure Therapeutics jumped more than 45% Monday after a new clinical study boosted...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 3 days agoSources Ozempic. FDA. Dr. Avantika Waring, MD, with 9amHealth Dr. Spencer Nadolsky, DO, an obesity...
Structure pill leads to competitive weight loss in obesity study
BioPharma Dive via Yahoo Finance· 6 days agoShares in the company soared by more than 50% as study data showed the pill led to similar levels of...
Structure's obesity pill surpasses expectations in mid-stage study
Reuters via AOL· 6 days ago(Reuters) -Structure Therapeutics said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations ...
The race for a weight loss pill heats up as a Novo Nordisk competitor releases new trial results
Quartz· 6 days agoIt’s the latest development in the race among several pharmaceutical companies to introduce new...
Weight loss medication complete guide: From Wegovy to Mounjaro
The Telegraph via Yahoo News· 4 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by...
What a Year on Ozempic Taught Johann Hari
The Atlantic· 2 days agoThe new book’s title is a slanted reference to Ozempic (which doesn’t come in pill form), and to the new class of anti-obesity medications that is...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy. | The Motley...
The Motley Fool· 6 days agoAmong other things, Amgen (AMGN 0.00%) is known for its collection of antibody therapies, many of which are indicated for treating various cancers. Now, it's putting that expertise with biologics ...
Viking says biopsy data confirm MASH drug’s benefit
BioPharma Dive via Yahoo Finance· 5 days agoWhile Madrigal launches that pill, which works the same way as VK2809, Viking is still years away from the market. The company is also now...